Q4 2023
Released Feb 21, 2024, after the close
10-K filed Feb 22, 2024, 53 days after period end · 0001653477-24-000009
Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$116.80M-$116.80M derivedN/M vs Q4 2022N/M vs Q3 2023
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$32,600,000−69.1%
Operating Incomederived$88,200,000+18.7%
Operating Cash Flowderived$46,200,000−53.1%
Free Cash Flowderived$17,000,000−65.5%
What the release said
The release
Same quarter
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | — | $383.60M | $336.00M | $325.60M |
| Net Income | -$116.80M | $15.60M | $29.30M | $46.00M |
| EPS Diluted | — | — | — | $1.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR